New drug aims to boost growth in kids with dwarfism

NCT ID NCT07297875

First seen Jan 05, 2026 · Last updated May 17, 2026 · Updated 21 times

Summary

This study tests a new medicine called ABSK061 in 110 children with achondroplasia (a common form of dwarfism). The goal is to see if it is safe and can help children grow taller. The study is open-label, meaning everyone knows they are getting the drug, and it will last for at least a year to check long-term effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACHONDROPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Children's Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

    Contact Email: •••••@•••••

    Contact

  • Chengdu Women's and Children's Central Hospital

    Chengde, Sichuan, China

  • Children's Hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • Henan Children's Hospital, Zhengzhou Children's Hospital

    Zhengzhou, Henan, China

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

    Contact

    Contact Email: •••••@•••••

    Contact

  • West China Second University Hospital, Sichuan University

    Chengdu, Sichuan, China

    Contact Email: •••••@•••••

    Contact

  • Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.